A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2Article Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% confidence interval access Accuracy acute respiratory syndrome Ag-RDT Ag-RDTs Analysis Antigen-detecting rapid diagnostic tests B.1.1.7 characterized circulating clinical Combination complement coronavirus COVID-19 Critical cycle threshold demonstrated diagnostic Emergency Emergency use evaluated facilitate Factor Germany gold standard highlight independent India multicenter nasopharyngeal Oropharyngeal overcome participant Participants performance performed point-of-care positive post-symptom onset questionnaire raised Rapid Rapid diagnostic test recruited resources reverse transcription-PCR RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection sensitivity specificity specificity. subgroup subgroups Support SUS Swab symptom duration symptom onset Symptoms Test Transmission variant Viral load was used WHO widespread World Health Organization [DOI] 10.1128/spectrum.01229-22 PMC 바로가기
Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic PatientsArticle Published on 2022-10-262022-11-16 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술, [키워드] Accuracy addition analyzed Antigen asymptomatic patient coronavirus COVID-19 cycle threshold Diagnosis diagnostic evaluated genes encoding immunochromatographic Infection information Interpretation methodology nasopharyngeal oropharyngeal swab Patient performed POC POC test point-of-care point-of-care test point-of-care testing provide rapid antigen test Rapid test rapid tests. reduce reproducibility reverse transcription-PCR RT-PCR Safe saline solution Sample SARS-CoV-2 sensitivity symptom onset symptomatic Symptomatic patients temperature Test tested the SARS-CoV-2 Variation Veritor test [DOI] 10.1128/spectrum.00190-22 PMC 바로가기
Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective studyArticle Published on 2022-10-202022-11-15 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] adverse events Algorithm antibody Antiviral antiviral drug antivirals approved benefit Calabria case sery clinical clinical evolution Combination combination therapy combined use coronavirus disease COVID-19 COVID-19 progression drug Early therapies early treatment effective Effectiveness Efficacy escape mutant group Health services hospital Hospital admission hospitalisation Hospitalized hypothesised Immunocompromised immunocompromised individuals implication increase in lesson mAb mAbs malignancy monoclonal antibodies monoclonal antibody monotherapy Patient patients patients treated progression provided receive reduce reported Retrospective study SARS-CoV-2 SARS-CoV-2 genome Support symptom onset Territorial health services. Therapies therapy treated treated patient Treatment [DOI] 10.1186/s12879-022-07774-9 PMC 바로가기
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19Article Published on 2022-10-192022-11-15 Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 치료제, [키워드] 95% CI Administered administration Adverse affected analysed antiviral therapy Antiviral treatment ARMS baseline changed Combination combination therapy concentrations conducted coronavirus 2 COVID-19 COVID-19 pandemic Day Dose escalation doses double-blind double-blind trial drug level effective Efficacy evaluate the effect event Favipiravir healthy Interaction Lopinavir-ritonavir measure monotherapy Odds ratio Outpatient participant Participants Phase 2 Placebo placebo-controlled placebo-controlled trial placebos plasma primary analysis Primary outcome provided randomised recruited reduced respiratory SARS-CoV-2 SARS-CoV-2 viral load significant interaction significantly study population symptom onset the mean trajectory Treatment undetectable United Kingdom Viral load virus [DOI] 10.1371/journal.pmed.1004120 PMC 바로가기
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort StudyArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome confidence interval Contact coronavirus coronavirus 2 cumulative determinant Epidemiology evaluated household household contact household contacts household transmission incidence increased risk increasingly individual Infection infectious viral shedding. Intervention longitudinal magnitude nasal occurred populations Primary outcome reduce respiratory risk of infection RNA SARS-CoV-2 SARS-COV-2 infection specimen Symptom symptom onset symptomatic symptomatic SARS-CoV-2 infection Transmission transmission of SARS-CoV-2 vaccination viral shedding [DOI] 10.1093/cid/ciac545 PMC 바로가기
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 PeriodsArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] addition age Antigen Asymptomatic booster children clinical symptom Community conducted cough COVID-19 COVID-19 symptom COVID-19 testing cross-sectional Delta Duration Evolution Fever first positive Fisher Health Isolation Latinx less loss of taste median myalgia negative test omicron outcome participant Participants Patient Period population immunity positive positive result positive test result Practitioner proportion public health Rapid remained repeated reported reported symptoms San Francisco SARS-COV-2 infection seeking Site sore throat Symptom symptom onset symptomatic symptomatic participant Symptoms Test tested Testing upper respiratory tract vaccination Vaccine variant Viral variants were used with COVID-19 worsening χ2 test [DOI] 10.1001/jamanetworkopen.2022.35844 PMC 바로가기
Environmental detection of SARS-CoV-2 in hospital rooms in different wards of a university hospitalArticle Published on 2022-10-012022-11-15 Journal: The Journal of hospital infection [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome age Analysis appear association clinical clinically close contact cohort of patient collected Compliance Contact Contamination coronavirus disease Coronavirus-2 COVID-19 Cross-transmission cycle threshold diagnosed with COVID-19 eight Environment Evidence FIVE hospital hygiene occur Patient patient symptom patients with COVID-19 Personal protective equipment polymerase chain positive sample precautions reverse transcription routine care RT-PCR Sample SARS-CoV-2 SARS-CoV-2 detection SARS-CoV-2. Support Swab Symptom symptom onset Symptoms university hospital was collected was performed [DOI] 10.1016/j.jhin.2022.07.029 PMC 바로가기
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsArticle Published on 2022-10-012022-11-15 Journal: Transfusion [Category] COVID19(2023년), SARS, 진단, [키워드] 28-day mortality acute respiratory syndrome administration adverse effects adverse event adverse events antibody antibody assay Antibody Response Antibody titers Antigen assays binding case-control study CCP Characteristics characterization Control Controlled trial convalescent convalescent plasma coronavirus COVID-19 COVID-19 convalescent plasma died disease severity Donor donors enrolled evaluated group had no heterogeneous hospital Hospitalized immune response Immunosuppressed median median age Microarray NAb Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing antibody assays neutralizing capacity not affect pathogen-reduction treatment. Patient Pneumonia recipient recipients response responses SARS CoV-2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV2 single-center survival symptom onset transfused transfusion treated Treatment variable with COVID-19 [DOI] 10.1111/trf.17083 PMC 바로가기
When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic reviewReview article Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 치료기술, [키워드] COVID-19 addition affected analyzed article Case series cohorts conducted coronavirus cough country COVID-19 COVID-19 testing Cross-sectional studies database described Dyspnea evaluate Fever first positive health units Infection initial symptom median age objective participant Patient patients polymerase chain positive positive test result real-time reverse transcriptase Real-time reverse transcriptase polymerase chain reaction reported Result retrospective cohorts RT-PCR RT-PCR test RT-PCR testing SARS-CoV-2 Symptom symptom onset systematic review the MEDLINE [DOI] 10.1016/j.ijid.2022.06.037 [Article Type] Review article
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY studyResearch article Published on 2022-10-012022-10-05 Journal: Breast (Edinburgh, Scotland) [Category] 진단, 치료기술, [키워드] affected analyzed Asymptomatic Breast Breast cancer Cancer Cooperative Coronavirus disease 2019 COVID-19 COVID-19 crisis COVID-19 outbreak Department diagnosed Diagnosis diagnostic delay early stage effective group incidence institution interval Italian late stage less management medical record multicenter Multidisciplinary discussions New pandemic Pathways performance status radiological Radiological Diagnosis reduction Result symptom onset symptoms onset therapeutic delay time interval Treatment were assessed [DOI] 10.1016/j.breast.2022.08.007 [Article Type] Research article